Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
3 publications have been identified in PubMed for idiopathic giant cell myocarditis. Research spans Review / Meta-Analysis (67%) and Case Report / Case Series (33%).
Marchetta M (2026). [PMID: 41558852](https://pubmed.ncbi.nlm.nih.gov/41558852/). *Heart (British Cardiac Society)*. [Review / Meta-Analysis]
Zhang W (2025). [PMID: 40078460](https://pubmed.ncbi.nlm.nih.gov/40078460/). *Frontiers in cardiovascular medicine*. [Case Report / Case Series]
Ezzeddine FM (2025). [PMID: 40286351](https://pubmed.ncbi.nlm.nih.gov/40286351/). *JACC. Advances*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning idiopathic giant cell myocarditis
Updated Aug 21, 2026
Recent research explores the immune pathogenesis of giant cell myocarditis, providing insights into contemporary management strategies. This study enhances understanding of the disease's underlying mechanisms and potential therapeutic approaches.